Found 13 matching trials
Intravesical BCG vs GEMDOCE in NMIBC PHASE3 The study hypothesis is that BCG naïve non-muscle invasive bladder cancer (...
Show More Status
Active Not Recruiting
Location
University of Alabama at Birmingham Cancer Center
Learn More & Join Trial
Intravesical GEM/DOCE for HR BCG-Unresponsive NMIBC PHASE2 The goal of this clinical trial is to learn whether a combination of two ch...
Show More Location
University of Iowa
Learn More & Join Trial
Intravesical Gemcitabine and Docetaxel for BCG naïve Non-muscle Invasive Bladder Cancer PHASE2 A single-arm, two-stage, open-label, phase 2 study investigating the safety...
Show More Status
Active Not Recruiting
Location
Johns Hopkins University: Sidney Kimmel Comprehensive Cancer Center
Learn More & Join Trial
Intravesical Chemotherapy in Combination With Systemic Pembrolizumab in NMIBC Unresponsive or Exposed to BCG Therapy PHASE2 interventional study of intravesical chemotherapy and sistemic immunotherap...
Show More Learn More & Join Trial
Gemcitabine and Docetaxel Therapy in High-risk BCG-naive Patients With Non-muscle Invasive Bladder Cancer NA Bacillus Calmette-Guerin (BCG) is the standard of care for high-risk patien...
Show More Location
University Hospital Centre Zagreb
Learn More & Join Trial
Sequential Intravesical Gemcitabine and Docetaxel for Rescue Therapy in BCG Unresponsive Non-muscle Invasive Bladder Cancer Patients N/A Studies in the literature are limited both throughout Turkey and in general...
Show More Location
Dokuz Eylul University Faculty of Medicine Department of Urology
Learn More & Join Trial
Intravesical Gem/Doce in Patients With NMIBC PHASE2 Intravesical immunotherapy or chemotherapy for non-muscle invasive bladder ...
Show More Status
Active Not Recruiting
Location
University of Arizona Cancer Center
Learn More & Join Trial
Intravesical Gemcitabine and Docetaxel for Low Grade Intermediate Risk Bladder Cancer PHASE2 Bladder cancer is the 8th most common cancer in the UF Health Cancer Center...
Show More Location
University of Florida
Learn More & Join Trial
A Study of Adjuvant NDV-01 (Sustained-release Gemcitabine-docetaxel) for the Treatment of Intermediate Risk NMIBC Following TURBT PHASE3 This is a Phase 3, open-label, randomized trial designed to evaluate the DF...
Show More Location
Multiple Locations
Learn More & Join Trial
A Trial to Evaluate Intravesical Nadofaragene Firadenovec Alone or in Combination With Chemotherapy or Immunotherapy in Participants With High-grade BCG Unresponsive Non-muscle Invasive Bladder Cancer PHASE3 The pivotal phase 3 trial (rAd-IFN-CS 003) evaluating the efficacy of nadof...
Show More Location
Center for Neurosciences
Learn More & Join Trial